Samsung Biologics

📍 Songdo, South Korea🗓 Founded 2011👥 2,167 employees💰 Last funded Jul 2022
Pharmaceutical Manufacturing🌐 samsungbiologics.com
Website LinkedIn
Samsung Biologics is a fully integrated CDMO offering state-of-the-art contract development and manufacturing services. With proven regulatory approvals, the largest capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to support the development and manufacturing of biologics products at every stage of the process while meeting the evolving needs of biopharmaceutical companies worldwide.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Saudi Arabia
1
Frequently asked questions
Who invested in Samsung Biologics?
Samsung Biologics has 1 investors on record on gritt.io.
When did Samsung Biologics last raise funding?
The most recent investment in Samsung Biologics recorded on gritt.io was in July 2022.
When was Samsung Biologics founded?
Samsung Biologics was founded in 2011.
What industry is Samsung Biologics in?
Samsung Biologics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Samsung Biologics based?
Samsung Biologics is headquartered in Songdo, South Korea.